Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.350
+0.090 (2.76%)
At close: Apr 28, 2026, 4:00 PM EDT
3.380
+0.030 (0.90%)
Pre-market: Apr 29, 2026, 4:15 AM EDT
Sana Biotechnology Employees
Sana Biotechnology had 142 employees as of December 31, 2025. The number of employees decreased by 52 or -26.80% compared to the previous year.
Employees
142
Change (1Y)
-52
Growth (1Y)
-26.80%
Revenue / Employee
n/a
Profits / Employee
-$1,719,479
Market Cap
919.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,300 |
| Maravai LifeSciences Holdings | 435 |
| MeiraGTx Holdings | 403 |
| Phathom Pharmaceuticals | 371 |
| Xencor | 260 |
| Janux Therapeutics | 109 |
| Alto Neuroscience | 68 |
| Compass Therapeutics | 39 |
SANA News
- 1 day ago - Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting - GlobeNewsWire
- 6 weeks ago - Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 2 months ago - Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Sana Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Sana Biotechnology to Present at March 2026 Investor Conferences - GlobeNewsWire
- 3 months ago - Sana Biotechnology Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform - GlobeNewsWire